Researchers discuss the results of a randomized controlled trial to explore the impact of diet on breast cancer recurrence.
Incyte is ‘optimistic’ about skin disease drug Opzelura as prescriptions grow 77% in Q4
Incyte expects its atopic dermatitis and vitiligo treatment Opzelura to be a “key contributor” to growth in 2024 after sales jumped 78% in the fourth